Home » Authors » Karen Young

Articles by Karen Young

Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study

March 1, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Restoragen Cuts Half Its Staff, Plans To Rework Business Plan

Feb. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 22, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.